Location History:
- Bellaire, TX (US) (2001)
- Houston, TX (US) (2013)
Company Filing History:
Years Active: 2001-2013
Title: Innovations by Inventor Pierre Zoldhelyi
Introduction
Pierre Zoldhelyi is a notable inventor based in Bellaire, Texas, known for his significant contributions to medical technology and therapies. With three patents to his name, Zoldhelyi's innovations focus on advancing treatments for ischemic conditions and preventing thrombus deposition in vascular systems.
Latest Patents
Zoldhelyi's most recent patents demonstrate his commitment to addressing critical health challenges. The first patent, “Mesodermal-like cell population for treating ischemia in mammals,” outlines compositions containing mesodermal-like multipotent mammalian mononuclear cells. These cells express both CD34 and M-cadherin surface markers and are utilized to prevent, treat, or reduce ischemia severity in mammals. This inventive approach can potentially repopulate sites in vivo with new myocytes and vascularize ischemic tissues effectively.
Another significant patent is the “Vasoprotective recombinant adenovirus vector containing a human TFPI gene.” This invention describes a recombinant adenoviral vector encoding the human tissue factor pathway inhibitor (TFPI) gene. The patent emphasizes the vector's usefulness in transducing vascular smooth muscle cells, providing local vascular expression of TFPI to serve as an in vivo antithrombotic agent. This innovative method offers protection against thrombus deposition and aims to deter the development of chronic vascular stenosis.
Career Highlights
Throughout his career, Zoldhelyi has collaborated with reputable institutions, enhancing his expertise and contributions to the field. Notably, he has worked with the Texas Heart Institute and the University of Texas System, where he has been involved in groundbreaking research and innovations focused on cardiovascular health.
Collaborations
Collaborating with esteemed colleagues such as James T Willerson and Qui Liu, Zoldhelyi has been part of initiatives that leverage multidisciplinary approaches to tackle complex medical issues. These collaborations emphasize the importance of teamwork in driving impactful innovations within healthcare.
Conclusion
Pierre Zoldhelyi's innovative work in developing novel therapeutic methods continues to pave the way for advancements in treating ischemic disorders and thrombotic complications. His patents reflect a strong commitment to enhancing patient care and improving medical outcomes. The impact of his inventions is significant and demonstrates the critical role that inventors play in shaping the future of medical technology.